Verition Fund Management LLC Gilead Sciences, Inc. Put Options Transaction History

Verition Fund Management LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $1.8 Million - $2.28 Million	27,100 Added 241.96%	38,300 $3.21 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $808,320 - $932,864	-12,800 Reduced 53.33%	11,200 $768,000
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $722,958 - $881,629	10,100 Added 72.66%	24,000 $1.76 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $1.02 Million - $1.15 Million	13,900 New	13,900 $1.13 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $1.1 Million - $1.25 Million	18,400 New	18,400 $1.14 Million
Q4 2021 May 03, 2022	SELL	$64.88 - $73.64 $5.95 Million - $6.75 Million	-91,700 Reduced 83.36%	18,300 $1.33 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $7.45 Million - $8.03 Million	110,000 New	110,000 $7.68 Million

1,930

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.